Page last updated: 2024-08-24

delphinidin and Epidermolysis Bullosa Junctionalis, Disentis Type

delphinidin has been researched along with Epidermolysis Bullosa Junctionalis, Disentis Type in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Kour, N; Rajagopal S, V; Rao, M; Rao, R; Singh, S1

Other Studies

1 other study(ies) available for delphinidin and Epidermolysis Bullosa Junctionalis, Disentis Type

ArticleYear
Platelet-rich plasma injection and becaplermin gel as effective dressing adjuvants for treating chronic nonhealing ulcers in patients with junctional epidermolysis bullosa.
    Journal of the American Academy of Dermatology, 2021, Volume: 84, Issue:4

    Topics: Adult; Bandages; Becaplermin; Chronic Disease; Epidermolysis Bullosa, Junctional; Female; Gels; Humans; Paraffin; Platelet-Rich Plasma; Re-Epithelialization; Silicon; Silver; Skin Ulcer; Surgical Sponges; Viscoelastic Substances; Wound Healing

2021